CITRYLL

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 03 Jul 2025 filing date already counts against anyone who files later.

Record

Serial number

79433624

Mark type

Stylized text

Filed

03 Jul 2025

Published for opposition

29 Sept 2026

Attorney of record

Bryce J. Maynard

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancers, asthma, COPD, lupus, rheumatoid arthritis, vasculitis, idiopathic pulmonary fibrosis, lung disease, colitis, organ damage due to sepsis, atherosclerosis and cardiovascular disease; therapeutic antibodies for human use for the treatment of cancers, asthma, COPD, lupus, rheumatoid arthritis, vasculitis, idiopathic pulmonary fibrosis, lung disease, colitis, organ damage due to sepsis, atherosclerosis and cardiovascular disease; therapeutic antibodies for human use for the prevention and treatment of autoimmune diseases; small molecules and synthetic peptides for the prevention and treatment of cancers, asthma, COPD, lupus, rheumatoid arthritis, vasculitis, idiopathic pulmonary fibrosis, lung disease, colitis, organ damage due to sepsis, atherosclerosis and cardiovascular disease

Owner

• Citryll BV, NL

Prosecution history

• 01 Sept 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 28 Aug 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 27 Aug 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 27 Aug 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 26 Mar 2026 — REFUSAL PROCESSED BY IB
• 27 Feb 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
• 27 Feb 2026 — REFUSAL PROCESSED BY MPU
• 31 Jan 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
• 30 Jan 2026 — NON-FINAL ACTION WRITTEN
• 29 Jan 2026 — ASSIGNED TO EXAMINER
• 28 Jan 2026 — APPLICATION FILING RECEIPT MAILED
• 28 Jan 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 23 Oct 2025 — LIMITATION FROM ORIGINAL APPLICATION ENTERED
• 02 Oct 2025 — SN ASSIGNED FOR SECT 66A APPL FROM IB